Director, BD Early Stage — CSL Behring
- Location
- Bern
- Contract
- full-time
- Posted
- 3 days ago
Role overview
The Director, BD Early Stage leads the assessment of earl y- stage external innovation opportunities from Due Diligence Stage 2 to negotiation of a Non-Binding Offer ( NBO ) .
The role integrates evolving scientific advances, therapeutic trends and market dynamics to guide CSL's long-range BD investment decisions in early - stage opportunities.
It provides deep subject-matter leadership and enterprise-level judgement to ensure potential partnerships and acquisitions advance CSL’s portfolio impact, scientific differentiation and competitive positioning.
- The Director, BD Early Stage leads the assessment of earl y- stage external innovation opportunities from Due Diligence Stage 2 to negotiation of a Non-Binding Offer ( NBO ) .
- The role integrates evolving scientific advances, therapeutic trends and market dynamics to guide CSL's long-range BD investment decisions in early - stage opportunities.
- & Accountabilities External Innovation Evaluation Leadership:
- Lead evaluation of early-stage external assets, technologies, platforms and modalities aligned to TA Strategy from Due Diligence Stage 2 through Governance to negotiation of NBO.
- CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
Main responsibilities
- & Accountabilities External Innovation Evaluation Leadership:
- Lead evaluation of early-stage external assets, technologies, platforms and modalities aligned to TA Strategy from Due Diligence Stage 2 through Governance to negotiation of NBO.
- Integrate scientific, clinical, mechanistic, regulatory and commercial evidence into holistic assessments of attractiveness, differentiation and enterprise and TA strategic fit.
- Development of Investment-Ready Assessments:
- Deliver investment-quality inputs such as valuation assumptions, scenario modelling, unmet need assessments, deal analogues and downstream implications (e.g., biomarker requirements, specialized development pathways, manufacturing needs).
- Translate complex scientific and clinical narratives into clear, concise and decision-ready recommendations for CSL senior leaders.
- Strategic Judgement and Opportunity Prioritization:
- Provide recommendations on progressing, deferring or declining opportunities based on enterprise priorities and the TA Strategy.
What the company offers
- CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
Application process
- Cross-Functional Partnership and Collaboration:
- Develop and maintain key external partnerships with potential partners in close collaboration with R&D Search.
- Partner with BD Transactions to shape valuation logic, risk scenarios, deal structures and diligence readiness for advanced opportunities.
- Engage with global cross-functional partners including Commercial, Medical, Clinical Development, Regulatory, Technical Operations, Strategy, Finance to inform integrated and robust evaluation outputs.
- Governance and Decision Support:
- Prepare high-quality evaluation summaries, strategic assessments and decision papers for enterprise governance (e.g.
- PRISM, REDC) and other senior bodies as needed (e.g. PDCa, IDC)
- Ensure evaluation outputs reflect analytical depth, strategic clarity, scientific credibility and integrated cross-functional perspectives.
Company and context
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function. JOB SPECIFICATIONS Education
- Bachelor’s degree in Life Sciences, Medicine, Pharmacy, Biology, Physiology or a related discipline (required) ;
- Advanced degree such as PhD, MD, PharmD, MSc, MBA, or equivalent scientific/commercial qualification ( strongly preferred) . Experience
- 5-10+ years in pharmaceutical/biotech with substantive exposure to Search & Evaluation, early ‑ stage BD, R&D strategy or new product planning
- Proven ability to assess scientific/commercial potential and influence governance decisions
- Demonstrated success evaluating external opportunities, leading negotiations and influencing cross-functional and senior-level decisions
- Experience partnering across R&D, Commercial, Finance, Regulatory, and Transactions in a global matrix
- Proven ability supporting investment cases and contribute meaningfully to diligence and strategic evaluations Competencies
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I) High analytical capab
Additional details
- Responsibilities & Accountabilities External Innovation Evaluation Leadership:
- Apply CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
- PRISM, REDC) and other senior bodies as needed (e.g.
- Support enterprise capital allocation and portfolio shaping discussions with clear strategic logic and evidence-driven recommendations. Team Leadership & Capability Development
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function. JOB SPECIFICATIONS
- Advanced degree such as PhD, MD, PharmD, MSc, MBA, or equivalent scientific/commercial qualification ( strongly preferred) .
- Proven ability supporting investment cases and contribute meaningfully to diligence and strategic evaluations
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I) High analytical capab
Notes and original content
- Responsibilities & Accountabilities
- External Innovation Evaluation Leadership:
- Support enterprise capital allocation and portfolio shaping discussions with clear strategic logic and evidence-driven recommendations.
- Team Leadership & Capability Development
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function.
- JOB SPECIFICATIONS
- Experience
- Competencies
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I)
- High analytical capab
Questions about this listing
What salary does CSL Behring offer for this role?
CSL Behring lists CHF 76'000 - 106'000 gross per year for this position in Bern. This is the salary published in the original listing (or, when the employer omits a figure, a realistic estimate for the role and sector) — the calculator on this site converts it to your actual net take-home once cross-border tax and social contributions are applied.
Is this a full-time role, and what type of contract does CSL Behring offer?
This listing is a full-time position. The contract type shown here comes directly from the employer's original posting; always confirm exact hours, notice period and probation length with CSL Behring during the application process, since these details can vary by role even within the same contract category.
Do I need a cross-border work permit for a role in Bern?
EU/EFTA residents living in the border zone of the country adjoining Canton Bern can apply for a G permit; the Swiss employer files it with that canton's migration office after the contract is signed. Border-zone rules and processing times vary by neighbouring country and canton, so confirm the specifics with Bern's cantonal migration office or with HR during the application.
How do I apply for this position at CSL Behring?
Use the "Apply now" button on this page — it links directly to CSL Behring's original listing at csl.wd1.myworkdayjobs.com, so your application goes straight to the employer's own applicant-tracking system. Frontaliere Ticino does not collect or forward applications itself.
